SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York. The company's management will host a fireside chat on September 4, 2024, at 10:45 a.m. Eastern Time.
Investors can listen to the conference call by registering through a provided link. The webcast will be available live on the 'Investors' section of SI-BONE's website and will be archived for at least 90 days after the event. This presentation offers an opportunity for investors to gain insights into SI-BONE's operations and future prospects in the medical device industry.
SI-BONE (Nasdaq: SIBN), un'azienda che sviluppa dispositivi medici focalizzati sui disturbi sacropelvici, ha annunciato la sua partecipazione alla 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley a New York. La direzione dell'azienda condurrà una conversazione informale il 4 settembre 2024, alle 10:45 ora orientale.
Gli investitori possono ascoltare la chiamata conferenza registrandosi tramite un link fornito. La trasmissione in diretta sarà disponibile nella sezione 'Investitori' del sito web di SI-BONE e sarà archiviata per almeno 90 giorni dopo l'evento. Questa presentazione offre un'opportunità agli investitori per ottenere approfondimenti sulle operazioni di SI-BONE e sulle sue prospettive future nel settore dei dispositivi medici.
SI-BONE (Nasdaq: SIBN), una compañía de dispositivos médicos enfocada en trastornos sacropélvicos, ha anunciado su participación en la 22ª Conferencia Anual Global de Salud de Morgan Stanley en Nueva York. La dirección de la empresa llevará a cabo una charla informal el 4 de septiembre de 2024, a las 10:45 a.m., hora del Este.
Los inversores pueden escuchar la llamada de conferencia registrándose a través de un enlace proporcionado. La transmisión en vivo estará disponible en la sección 'Inversores' del sitio web de SI-BONE y se archivará durante al menos 90 días después del evento. Esta presentación ofrece a los inversores la oportunidad de obtener información sobre las operaciones de SI-BONE y sus perspectivas futuras en la industria de dispositivos médicos.
SI-BONE (Nasdaq: SIBN)은 천골골반 질환에 중점을 둔 의료기기 회사로, 뉴욕에서 열리는 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2024년 9월 4일 오전 10:45 (동부 표준시)에 대화형 세션을 주최할 예정입니다.
투자자들은 제공된 링크를 통해 등록하여 컨퍼런스 콜을 들을 수 있습니다. 웹캐스트는 SI-BONE 웹사이트의 '투자자' 섹션에서 실시간으로 제공되며, 이벤트 이후 최소 90일 동안 아카이브됩니다. 이 발표는 투자자들이 SI-BONE의 운영 및 의료기기 산업 내 미래 전망에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
SI-BONE (Nasdaq: SIBN), une entreprise de dispositifs médicaux axée sur les troubles sacropelviens, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley à New York. La direction de l'entreprise animera un échange informel le 4 septembre 2024, à 10h45, heure de l'Est.
Les investisseurs peuvent écouter l'appel de conférence en s'inscrivant via un lien fourni. La diffusion en direct sera disponible sur la section 'Investisseurs' du site Web de SI-BONE et sera archivée pendant au moins 90 jours après l'événement. Cette présentation offre aux investisseurs l'occasion d'obtenir des informations sur les opérations de SI-BONE et ses perspectives futures dans l'industrie des dispositifs médicaux.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen, das sich auf sakral-pelvine Störungen konzentriert, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley in New York bekannt gegeben. Das Management des Unternehmens wird am 4. September 2024 um 10:45 Uhr (Eastern Time) ein informelles Gespräch leiten.
Investoren können anrufen, indem sie sich über einen bereitgestellten Link registrieren. Der Live-Stream wird in der Rubrik 'Investoren' auf der Website von SI-BONE verfügbar sein und wird für mindestens 90 Tage nach der Veranstaltung archiviert. Diese Präsentation bietet Investoren die Möglichkeit, Einblicke in die Aktivitäten von SI-BONE und deren zukünftige Perspektiven im Bereich der Medizintechnik zu gewinnen.
- None.
- None.
SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Management will be hosting a fireside chat on Wednesday, September 4, 2024, at 10:45 a.m. Eastern Time / 7:45 a.m. Pacific Time.
Investors interested in listening to the conference call may do so by registering at this link: https://url.us.m.mimecastprotect.com/s/r-x6CjRnDNsnPR3wF7sxumTszz?domain=cc.webcasts.com. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 3,900 physicians in performing a total of over 100,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 130 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation and pelvic trauma.
For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.
iFuse Bedrock Granite, iFuse-TORQ, SI-BONE and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2024 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal investors@si-bone.com
FAQ
When is SI-BONE (SIBN) presenting at the Morgan Stanley Healthcare Conference?
How can investors listen to SI-BONE's (SIBN) presentation at the Morgan Stanley conference?
How long will the webcast of SI-BONE's (SIBN) presentation be available for replay?
What is the focus of SI-BONE's (SIBN) business?
